Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'
Ramirez G. A.
Primo
;Della Torre E.Secondo
;Dagna L.
2021-01-01
File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
e159.full.pdf
accesso aperto
Descrizione: All articles and resources listed at https://bmj.com/coronavirus are freely available for the duration of the covid-19 pandemic or until otherwise determined by BMJ. They may be downloaded or printed for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'autore
Dimensione
211.57 kB
Formato
Adobe PDF
|
211.57 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.